Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

 From the start you can see that the stroke medical world has the wrong goals for research! Restoring blood flow IS NOT THE SURVIVORS PRIMARY GOAL! 100% RECOVERY IS!

As you can see the stroke medical world has NO understanding of how to run the business of stroke recovery!

You're not even trying for 100% recovery! You're fired!

“What's measured, improves.” So said management legend and author Peter F. Drucker 

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

ClinicalTrials.gov ID NCT05152524

 Sponsor Rapid Medical 

Information Provided by 

Study Start (Actual)2022-03-25 

Primary Completion (Estimated) 2025-11 

Study Completion (Estimated)2026-01 

Enrollment (Estimated)168

Study TypeInterventional

Last Update Posted2025-07-23

Study Overview

Brief Summary

The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.ClinicalTrials.gov